Biologically pure culture of Streptomyces majorciensis Labeda
    9.
    发明授权
    Biologically pure culture of Streptomyces majorciensis Labeda 失效
    链霉菌的生物孔培养Labeda

    公开(公告)号:US4608343A

    公开(公告)日:1986-08-26

    申请号:US739334

    申请日:1985-05-30

    IPC分类号: C12P1/06 C12P21/00 C12P13/00

    CPC分类号: C12P1/06

    摘要: This disclosure describes four new antibacterial agents designated LL-C08078.alpha..sub.1, LL-C08078.alpha..sub.2, LL-C08078.alpha..sub.3 and LL-C08078.beta. produced in a microbiological fermentation under controlled conditions using a new strain of a new species of the genus Streptomyces called Streptomyces majorciensis Labeda, sp. nov., and mutants thereof. These new antibacterial agents are active against a variety of microorganisms and thus are useful in inhibiting the growth of such bacteria wherever they may be found. In addition, these agents are active as growth promotants in warm-blooded animals.

    摘要翻译: 本公开描述了在受控条件下使用新型链霉菌属的新菌株在微生物发酵中产生的四种新的抗菌剂,称为LL-C08078α1,LL-C08078α2,LL-C08078α3和LL-C08078ββ 称为Streptomyces majorciensis Labeda,sp。 nov。及其突变体。 这些新的抗菌剂对各种微生物具有活性,因此可用于抑制这些细菌的生长。 此外,这些试剂在温血动物中作为生长促进剂是有活性的。